Home/Filings/4/0001104659-20-042578
4//SEC Filing

Schranz Jennifer 4

Accession 0001104659-20-042578

CIK 0001641640other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:47 PM ET

Size

4.5 KB

Accession

0001104659-20-042578

Insider Transaction Report

Form 4
Period: 2020-03-31
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-03-31$0.57/sh301$173169,648 total

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001735382

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:47 PM ET
Size
4.5 KB